Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses

BACKGROUND: Thymomas and thymic carcinoma are rare tumors with no approved therapies. Our purpose was to analyze the molecular features and outcomes of patients referred to the Clinical Center for Targeted Therapy (Phase I Clinic). METHODS: We retrospectively reviewed the medical records of consecut...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheler, Jennifer, Hong, David, Swisher, Stephen G., Falchook, Gerald, Tsimberidou, Apostolia M., Helgason, Thorunn, Naing, Aung, Stephen, Bettzy, Janku, Filip, Stephens, Philip J., Yelensky, Roman, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757246/
https://www.ncbi.nlm.nih.gov/pubmed/23765114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757246/
https://www.ncbi.nlm.nih.gov/pubmed/23765114

Ejemplares similares